This service is more advanced with JavaScript available, learn more at http://activatejavascript.org

Reactions Weekly

September 2017, Volume 1668, Issue 1, pp 297–297 | Cite as

Nintedanib/pirfenidone

Severe upper gastrointestinal bleeding and non-ST segment elevation myocardial infarction: 2 case reports

Case report

First Online: 09 September 2017

38 Downloads

This is a preview of subscription content, to check access.

Reference

Galli JA, et al. Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions. Respirology 22: 1171-1178, No. 6, Aug 2017. Available from: URL: http://doi.org/10.1111/resp.13024 -USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

About this article

Cite this article as:: Reactions Weekly (2017) 1668: 297. https://doi.org/10.1007/s40278-017-35769-3

DOI https://doi.org/10.1007/s40278-017-35769-3
Publisher Name Springer International Publishing
Print ISSN 0114-9954
Online ISSN 1179-2051

Published in cooperation with
Adis

Personalised recommendations